NLG919 [1402836-58-1]
N4524
Estimated Purity≥98%
Product group Chemicals
Overview
- SupplierLKT Laboratories
- Product NameNLG919 [1402836-58-1]
- Delivery Days Customer7
- CertificationResearch Use Only
- Estimated Purity≥98%
- FormatEthanol 30 mg/mL (106.23 mM); DMSO 15 mg/mL warmed (53.11 mM); Water Insoluble
- Scientific DescriptionIndoleamine-2,3-dioxygenase inhibitor.
- Storage Instruction-20°C
- UNSPSC12352200
References
- Vacchelli E, Aranda F, Eggermont A, et al. Trial watch: IDO inhibitors in cancer therapy. Oncoimmunology. 2014 Dec 15;3(10):e957994. PMID: 25941578. Li M, Bolduc AR, Hoda MN, et al. The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma. J Immunother Cancer. 2014 Jul 7;2:21. PMID: 25054064.